Lee S, Kim S, Koh G, Ahn H
J Pers Med. 2024; 14(8).
PMID: 39202004
PMC: 11355743.
DOI: 10.3390/jpm14080812.
Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M
Int J Clin Oncol. 2023; 28(8):999-1010.
PMID: 37338727
PMC: 10390357.
DOI: 10.1007/s10147-023-02362-6.
Mori M, Miwa S, Ikari T, Kako J, Hasegawa T, Matsunuma R
Curr Treat Options Oncol. 2023; 24(6):565-579.
PMID: 37037975
DOI: 10.1007/s11864-023-01081-4.
Ekstrom M, Ferreira D, Chang S, Louw S, Johnson M, Eckert D
JAMA. 2022; 328(20):2022-2032.
PMID: 36413230
PMC: 9682426.
DOI: 10.1001/jama.2022.20206.
Coccolini F, Corradi F, Sartelli M, Coimbra R, Kryvoruchko I, Leppaniemi A
World J Emerg Surg. 2022; 17(1):50.
PMID: 36131311
PMC: 9494880.
DOI: 10.1186/s13017-022-00455-7.
Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians.
Matsuda Y, Matsunuma R, Suzuki K, Mori M, Watanabe H, Yamaguchi T
Palliat Med Rep. 2021; 1(1):97-102.
PMID: 34223464
PMC: 8241347.
DOI: 10.1089/pmr.2020.0050.
Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15).
Matsuda Y, Morita T, Oyamada S, Ariyoshi K, Yamaguchi T, Iwase S
BMJ Open. 2021; 11(5):e043156.
PMID: 34006542
PMC: 8130746.
DOI: 10.1136/bmjopen-2020-043156.
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Feliciano J, Waldfogel J, Sharma R, Zhang A, Gupta A, Sedhom R
JAMA Netw Open. 2021; 4(2):e2037632.
PMID: 33630086
PMC: 7907959.
DOI: 10.1001/jamanetworkopen.2020.37632.
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.
Mori M, Yamaguchi T, Matsuda Y, Suzuki K, Watanabe H, Matsunuma R
ESMO Open. 2021; 5 Suppl 1:e000603.
PMID: 33558034
PMC: 7046422.
DOI: 10.1136/esmoopen-2019-000603.
End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report.
Goda K, Kenzaka T, Kuriyama K, Hoshijima M, Akita H
World J Clin Cases. 2020; 8(20):4853-4857.
PMID: 33195653
PMC: 7642529.
DOI: 10.12998/wjcc.v8.i20.4853.
Use of short-acting opioids in the management of breathlessness: an evidence-based review.
Hui D, Bruera E
Curr Opin Support Palliat Care. 2020; 14(3):167-176.
PMID: 32701856
PMC: 8519016.
DOI: 10.1097/SPC.0000000000000509.
Effects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101).
Takahashi K, Kondo M, Ando M, Shiraki A, Nakashima H, Wakayama H
Oncologist. 2019; 24(7):e583-e589.
PMID: 30659079
PMC: 6656455.
DOI: 10.1634/theoncologist.2018-0468.
Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.
Strieder M, Pecherstorfer M, Kreye G
Wien Med Wochenschr. 2017; 168(13-14):333-343.
PMID: 28921042
DOI: 10.1007/s10354-017-0600-4.
Palliative Care for Patients with Nonmalignant Respiratory Disease.
Gupta N, Garg R, Kumar V, Bharati S, Mishra S, Bhatnagar S
Indian J Palliat Care. 2017; 23(3):341-346.
PMID: 28827944
PMC: 5545966.
DOI: 10.4103/IJPC.IJPC_14_17.
Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D, Kilgore K, Frisbee-Hume S, Park M, Liu D, Balachandran D
J Pain Symptom Manage. 2017; 54(6):798-805.
PMID: 28803087
PMC: 5705410.
DOI: 10.1016/j.jpainsymman.2017.08.001.
Off-Label Medication Use in the Inpatient Palliative Care Unit.
Kwon J, Kim M, Bruera S, Park M, Bruera E, Hui D
J Pain Symptom Manage. 2017; 54(1):46-54.
PMID: 28479415
PMC: 5841461.
DOI: 10.1016/j.jpainsymman.2017.03.014.
Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
Hui D, Kilgore K, Park M, Williams J, Liu D, Bruera E
J Pain Symptom Manage. 2016; 52(4):459-468.e1.
PMID: 27401508
PMC: 5075501.
DOI: 10.1016/j.jpainsymman.2016.05.013.
Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial.
Bauml J, Haas A, Simone 2nd C, Li S, Cohen R, Langer C
Integr Cancer Ther. 2016; 15(3):326-32.
PMID: 27114385
PMC: 5739187.
DOI: 10.1177/1534735415624138.
Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
Barnes H, McDonald J, Smallwood N, Manser R
Cochrane Database Syst Rev. 2016; 3:CD011008.
PMID: 27030166
PMC: 6485401.
DOI: 10.1002/14651858.CD011008.pub2.
Long-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patients.
Takakuwa O, Oguri T, Maeno K, Murase H, Asano T, Ichikawa H
Oncol Lett. 2015; 9(5):2105-2108.
PMID: 26137021
PMC: 4462562.
DOI: 10.3892/ol.2015.3022.
